Completed Diabetes, Hormones & Metabolism NIHR-supported project Digestion, Kidneys & Other Organs

Asteroid

Funder NIHR (part of DHSC)
Recipient organisation NIHR Exeter Biomedical Research Centre
NIHR support Recorded as supported by this research centre
Period Feb 2025 — Mar 2026

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by NIHR.

Researchers

Marianne Hollyman (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Astraea - t3
ASTEROID: A Phase I trial of ASTX660 in Combination with Pembrolizumab
ASTEROID: A Phase I trial of ASTX660 in combination with Pembrolizumab in patients with solid tumours: utilizing triple IAP blockade as a strategy to maximize Immunogenic cell Death and the generation of an efficient adaptive immune response
Astraea (e4)
Astraea(t6)

Original classification

Rehabilitation

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.